BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37681503)

  • 1. Does genetic risk modify the effect of skin screening on melanoma detection rates?
    Pandeya N; Dusingize JC; Olsen CM; MacGregor S; Neale RE; Law MH; Whiteman DC
    Br J Dermatol; 2023 Dec; 190(1):37-44. PubMed ID: 37681503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of screening on melanoma incidence and biopsy rates.
    Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
    Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population.
    Olsen CM; Pandeya N; Dusingize JC; Neale RE; MacGregor S; Law MH; Whiteman DC;
    JAMA Dermatol; 2023 Jan; 159(1):37-46. PubMed ID: 36416830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
    Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
    JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.
    Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E
    JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.
    Ferris LK; Saul MI; Lin Y; Ding F; Weinstock MA; Geller AC; Yuan JM; Neuren E; Maddukuri S; Solano FX; Kirkwood JM
    JAMA Oncol; 2017 Aug; 3(8):1112-1115. PubMed ID: 28241191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
    Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
    JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for reducing morbidity and mortality in malignant melanoma.
    Johansson M; Brodersen J; Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012352. PubMed ID: 31157404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevi, family history, and fair skin increase the risk of second primary melanoma.
    Siskind V; Hughes MC; Palmer JM; Symmons JM; Aitken JF; Martin NG; Hayward NK; Whiteman DC
    J Invest Dermatol; 2011 Feb; 131(2):461-7. PubMed ID: 20944647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Melanoma Detected During Routine Skin Checks and Mortality.
    Watts CG; McLoughlin K; Goumas C; van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE
    JAMA Dermatol; 2021 Dec; 157(12):1425-1436. PubMed ID: 34730781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
    Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
    JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and Risk Factors in Patients with Multiple Primary Melanomas.
    Nosrati A; Yu WY; McGuire J; Griffin A; de Souza JR; Singh R; Linos E; Chren MM; Grimes B; Jewell NP; Wei ML
    J Invest Dermatol; 2019 Jan; 139(1):195-201. PubMed ID: 30031745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and Cutaneous Melanoma: Findings from the QSkin Sun and Health Cohort Study.
    Dusingize JC; Olsen CM; Pandeya N; Thompson BS; Webb PM; Green AC; Neale RE; Whiteman DC;
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):874-881. PubMed ID: 29789324
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study.
    Afzal S; Nordestgaard BG; Bojesen SE
    J Invest Dermatol; 2013 Mar; 133(3):629-636. PubMed ID: 23190899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunscreen Use and Melanoma Risk Among Young Australian Adults.
    Watts CG; Drummond M; Goumas C; Schmid H; Armstrong BK; Aitken JF; Jenkins MA; Giles GG; Hopper JL; Mann GJ; Cust AE
    JAMA Dermatol; 2018 Sep; 154(9):1001-1009. PubMed ID: 30027280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
    Stang A; Jöckel KH; Heidinger O
    Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
    Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
    Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.